NRX Pharmaceuticals
NRXP
NRXP
7 hedge funds and large institutions have $5.22M invested in NRX Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-6
Holders Change %
-46.15%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
+$993K |
2 |
UBS Group
Zurich,
Switzerland
|
+$3.25K |
3 |
BCM
Bluefin Capital Management
New York
|
+$14 |